Загрузка страницы

Parallax | Ep 2: Role of High-Sensitivity Cardiac Troponin in Acute Coronary Syndrome

Ep 2: Role of High-Sensitivity Cardiac Troponin in Acute Coronary Syndrome with Santiago Garcia

Ankur is back with his second #AudioArticle! This week he spoke with Santiago Garcia from the Minneapolis Heart Institute about Santiago’s US Cardiology Review 13.1 article on the role of high-sensitivity cardiac troponin (hscTn) assays and their ability to rapidly rule in or rule out acute coronary syndrome (ACS) with improved sensitivity. Chest pain is one of the most common reasons for an emergency room visit in the US, with almost 6 million ER visits annually, yet there is no consensus on how to compare the results from various hscTn assays. Tune in to hear Santiago outline the advantages and limitations of using hscTn as a standard biomarket to evaluate patients with suspected ACS in the ER. Hosted by @AnkurKalraMD. Produced by @RadcliffeCardiology.

Follow us:
Twitter:
@AnkurKalraMD hyperlink to https://twitter.com/AnkurKalraMD
@radcliffeCARDIO hyperlink to https://twitter.com/radcliffeCARDIO

Facebook:
Ankur Kalra MD hyperlink to https://www.facebook.com/kalramd.ankur/
Radcliffe Cardiology hyperlink to https://www.facebook.com/RadcliffeCardiology/

YouTube:
Radcliffe Group hyperlink to https://www.youtube.com/channel/UCmJZXhuw-rlWXhlP0s26TXA

More information on Ankur and US Cardiology journal:
https://www.uscjournal.com
http://www.ankurkalramd.com

Register today for regular updates on other Radcliffe Cardiology projects:
https://www.radcliffecardiology.com

Email us thoughts, comments and questions:
podcast@radcliffe-group.com

Видео Parallax | Ep 2: Role of High-Sensitivity Cardiac Troponin in Acute Coronary Syndrome канала Radcliffe Cardiology
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
8 апреля 2020 г. 13:12:28
00:29:56
Другие видео канала
ESC 2022: The ALL-HEART Trial: Allopurionol in the Treatment of Ischaemic Heart DiseaseESC 2022: The ALL-HEART Trial: Allopurionol in the Treatment of Ischaemic Heart DiseaseComing Soon | Parallax by Ankur Kalra Season 5!Coming Soon | Parallax by Ankur Kalra Season 5!Journal Club: Pre-procedural Planning for Pulsed-Field AblationJournal Club: Pre-procedural Planning for Pulsed-Field AblationLINC 2022: IN.PACT Global Study 5-Y Diabetic & Gender Subgroup Outcomes | Dr Marianne BrodmannLINC 2022: IN.PACT Global Study 5-Y Diabetic & Gender Subgroup Outcomes | Dr Marianne BrodmannEuroPCR 2019: JenaValve™ TAVI System - Prof Stephan BaldusEuroPCR 2019: JenaValve™ TAVI System - Prof Stephan BaldusCRT 2020: Anticoagulation vs antiplatelet therapy after TAVR — Dr Toby RogersCRT 2020: Anticoagulation vs antiplatelet therapy after TAVR — Dr Toby RogersNew ESC Guidelines on Valvular Heart Disease at PCR London Valves 2017New ESC Guidelines on Valvular Heart Disease at PCR London Valves 2017Radcliffe & CardioNerds @AHA22: The ECMO-CS TrialRadcliffe & CardioNerds @AHA22: The ECMO-CS TrialThe Big Challenge in Atherectomy: Rotational, Orbital or Directional?The Big Challenge in Atherectomy: Rotational, Orbital or Directional?ESC 24: MRAs in Heart FailureESC 24: MRAs in Heart FailureACC 22: FFR vs. IVUS-guided PCI in Intermediate Coronary Artery Stenosis: The FLAVOUR Trial | Dr KooACC 22: FFR vs. IVUS-guided PCI in Intermediate Coronary Artery Stenosis: The FLAVOUR Trial | Dr KooLINC 2022: PRIZER Study With Dr Deloose: Renzan™ Stent in Pts With PADLINC 2022: PRIZER Study With Dr Deloose: Renzan™ Stent in Pts With PADACC 23: Statins to Protect Heart During Cancer Treatment: The STOP-CA TrialACC 23: Statins to Protect Heart During Cancer Treatment: The STOP-CA TrialAHA 2021: AXIOMATIC-TKR: Patients Treated with Milvexian Show Reduced Rate of Venous ThromboembolismAHA 2021: AXIOMATIC-TKR: Patients Treated with Milvexian Show Reduced Rate of Venous ThromboembolismAHA 2021 Late-Breaker Discussion: The EMPULSE TrialAHA 2021 Late-Breaker Discussion: The EMPULSE TrialEuroPCR 2019: The ABSORB UK Registry - Everolimus-eluting BRS - Dr Nick WestEuroPCR 2019: The ABSORB UK Registry - Everolimus-eluting BRS - Dr Nick WestParallax | Ep 73: Passion, Faith & Entrepreneurship with Prof Carolyn Lam, Clinician ScientistParallax | Ep 73: Passion, Faith & Entrepreneurship with Prof Carolyn Lam, Clinician ScientistVEINS 22: ABRE Study: Abre Venous Stent in Patients With Venous Outflow Obstruction | Prof BlackVEINS 22: ABRE Study: Abre Venous Stent in Patients With Venous Outflow Obstruction | Prof BlackVEITH 2021: PROMISE I shows CLTI Patients Gain Greater Freedom From Amputation With LimFlow SystemVEITH 2021: PROMISE I shows CLTI Patients Gain Greater Freedom From Amputation With LimFlow SystemACC 22: Findings From the PARTITA Trial | Dr Paolo Della BellaACC 22: Findings From the PARTITA Trial | Dr Paolo Della BellaHF 2022: SCD Risk Protection for Newly Diagnosed HF Patients | Dr José González-CostelloHF 2022: SCD Risk Protection for Newly Diagnosed HF Patients | Dr José González-Costello
Яндекс.Метрика